文献速递主动脉疾病

择期血管腔内修复肾下腹主动脉瘤后的心脏风险:意大利EVAR多中心注册研究结果

Cardiac risk after elective endovascular repair for infrarenal abdominal aortic aneurysm: Results from the Italian Collaborators for EVAR multicenter registry.
PubMed 文献 · J Vasc Surg · 2023-10-05

该多中心回顾性观察队列研究纳入2018年1月至2021年3月四家学术三级转诊医院497例择期EVAR患者,评估术后主要不良心脏事件(MACE)。MACE发生率为6.4%(32/497),多数事件发生于术后(24/32,75%);围术期需红细胞输注与MACE发生及1年死亡相关。

要点

  • 择期EVAR后MACE发生率为6.4%(32/497),多数事件发生于术后期(24/32,75%)。
  • 围术期需红细胞输注与MACE发生相关(OR 2.67,95%CI 1.52-4.68,P=.001)。
  • 围术期需红细胞输注与1年死亡相关(HR 2.14,95%CI 1.48-3.09,P=.0001)。

核心结论

  • MACE是择期EVAR术后及早期常见并发症,需红细胞输注的失血与术后MACE及早期死亡增加相关,作者认为应尽一切努力减少择期干预期间及之后的出血。

研究设计与样本

  • 多中心、回顾性、无资金支持的医生发起的观察性队列研究,由四家学术三级转诊医院于2018年1月至2021年3月开展,纳入497例择期EVAR患者(女性35例,7%),平均年龄75.3±7.8岁。

主要发现

  • MACE发生率为6.4%(32/497),其中多数事件记录于术后期(24/32,75%;总体24/497,4.8%)。
  • 1年全因生存率为94%(95%CI 91-96),MACE人群生存估计率显著低于总体人群(总体-MACE:95.8%[95%CI 93-97]对67.9%[95%CI 47-82],log-rank 41.950,P=.0001)。
  • 免于主动脉相关死亡率为99.3%(95%CI 98-100)。
  • 围术期需红细胞输注与MACE发生强烈相关(OR 2.67,95%CI 1.52-4.68,P=.001),与1年死亡相关(HR 2.14,95%CI 1.48-3.09,P=.0001)。

关键数值与推荐

  • MACE定义为急性冠脉综合征、非ST段抬高型心肌梗死、不稳定型心绞痛、新发心房颤动、心力衰竭住院、血运重建及心血管死亡。

临床怎么用

  • 作者认为应尽一切努力减少择期干预期间及之后的出血。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Major adverse cardiac events (MACEs) were common complications after endovascular aortic repair (EVAR) causing significant postoperative morbidity and mortality. The aim of the study was to evaluate the cardiac risk after elective EVAR for uncomplicated noninfected infrarenal abdominal aortic aneurysm in a large multicenter cohort. METHODS: This is a multicenter, retrospective, financially unsupported physician-initiated observational cohort study conducted by four academic tertiary referral hospitals from January 2018 to March 2021. Baseline, perioperative, and postoperative information of elective EVARs was evaluated. The primary outcome was the incidence of MACEs after EVAR, which was defined as acute coronary syndrome, non-ST-elevation myocardial infarction, unstable angina pectoris, de novo atrial fibrillation, hospitalization for heart failure, and revascularization as well as cardiovascular death. Secondary outcomes were 1-year overall survival (all-cause mortality) and freedom from aorta-related mortality. Comparative analysis was conducted between MACE and overall population, and univariate and multivariate logistic regression analyses were used to analyze factors associated with the risk of the MACE occurrence and early 1-year mortality. RESULTS: The study has enrolled 497 patients (35 females, 7%) with a mean age of 75.3 ± 7.8 years. The MACE rate was 6.4% (32/497, events/patients), and the majority of the events were recorded in the postoperative period (24/32, 75%; overall 24/497, 4.8%). One-year survival from all-cause mortality was 94% (95% confidence interval [CI]: 91-96), and the MACE population showed a significantly lower survival estimation rate (Overall - MACEs, 95.8% [95% CI: 93-97] - 67.9% [95% CI: 47-82], log-rank 41.950, P = .0001). Freedom from aorta-related mortality was 99.3% (95% CI: 98-100). The perioperative need for red blood cell transfusions was strongly related to the MACE occurrence (odds ratio: 2.67, 95% CI: 1.52-4.68, P = .001) and 1-year mortality (hazard ratio: 2.14, 95% CI: 1.48-3.09, P = .0001). CONCLUSIONS: MACEs represent a common complication in the postoperative and early period after elective EVAR. Blood loss requiring red blood cell transfusions is associated with increased postoperative MACEs and early mortality, suggesting that all the efforts should be carried out to reduce the bleeding during and after elective interventions.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zacà S, Di Stefano L, Esposito D, et al. Cardiac risk after elective endovascular repair for infrarenal abdominal aortic aneurysm: Results from the Italian Collaborators for EVAR multicenter registry. J Vasc Surg. 2023. PMID: 37804956. doi:10.1016/j.jvs.2023.09.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。